FERRARA, IDALUCIA
 Distribuzione geografica
Continente #
NA - Nord America 387
EU - Europa 77
AS - Asia 25
Continente sconosciuto - Info sul continente non disponibili 1
Totale 490
Nazione #
US - Stati Uniti d'America 387
IT - Italia 42
CN - Cina 17
IE - Irlanda 11
TR - Turchia 8
UA - Ucraina 6
DE - Germania 5
SE - Svezia 5
GB - Regno Unito 4
CZ - Repubblica Ceca 1
ES - Italia 1
EU - Europa 1
FI - Finlandia 1
GR - Grecia 1
Totale 490
Città #
Ashburn 83
Chandler 57
Woodbridge 39
Princeton 34
Ann Arbor 27
Wilmington 24
Houston 21
Naples 12
Dublin 11
Jacksonville 11
Washington 9
Izmir 8
Beijing 5
Cava De' Tirreni 5
Salerno 5
Fairfield 3
Nanjing 3
Pellezzano 3
Piacenza 3
Trieste 3
Andover 2
Castel San Lorenzo 2
Changsha 2
Düsseldorf 2
Ferrara 2
Redwood City 2
Southend 2
Boardman 1
Brno 1
Caserta 1
Cuckfield 1
Ealing 1
Guangzhou 1
Gunzenhausen 1
Hebei 1
Jiaxing 1
Lappeenranta 1
Madrid 1
Nanchang 1
New York 1
Seattle 1
Zhengzhou 1
Totale 395
Nome #
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation. Bone Marrow Transplantation 85
Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment. 67
Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia. 61
Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens 46
A simple flow cytometric score based on CD49d and homing marker expression in chronic lymphocytic leukemia (CLL). 36
OPSI threat in hematological patients 31
The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma 30
WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes 27
Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study 20
Persistent decreased bone marrow CD3+CD56+ T lymphocytes are inversely associated with mature granulocytes in myelodysplastic syndromes 16
Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study 15
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 14
Low-Density Granulocytes Are Decreased in Acute Myeloid Leukemia and in Myelodysplastic Syndromes with Negative Prognostic Factors 13
SERUM FREE LIGHT CHAIN RATIO AS A BIOMARKER OF MULTIPLE MYELOMA PROGRESSION AND ASSOCIATED RENAL DISEASE 13
Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience 13
Multiple myeloma characteristics correlated to serum free light chain ratio at diagnosis and association with early renal damage 12
INTENSIFICATION AND MAINTENANCE WITH RITUXIMAB IN PATIENTS WITH DLBCL IN UNCERTAIN CR OR PR (PET-ORIENTED) AFTER INDUCTION THERAPY WITH R-CHOP OR SIMILAR THERAPIES; OUR EXPERIENCE 10
DECREASED LOW-DENSITY GRANULOCYTES AS POSSIBLE DIAGNOSTIC MARKERS OF MYELODYSPLASTIC SYNDROMES WITH EXCESS OF BLASTS 8
INCREASE OF BONE EVENTS (FRACTURES) IN PATIENTS WITH AGGRESSIVE NON-HODGKIN LYMPHOMA: NEGATIVE SYNERGISM BETWEEN STEROIDS AND LOW MOLECULAR WEIGHT HEPARIN (LMWH)? OUR EXPERIENCE 7
Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition 5
Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients 4
Totale 533
Categoria #
all - tutte 2.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.440


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 1 8 0
2019/202018 8 0 3 0 1 0 1 0 1 1 3 0
2020/202144 0 0 0 0 10 1 3 0 1 9 15 5
2021/202251 4 0 3 5 2 0 0 0 2 4 8 23
2022/2023131 9 7 11 10 12 28 12 13 15 0 12 2
2023/2024159 19 15 16 10 19 38 31 9 2 0 0 0
Totale 533